A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 5,892 shares of VRTX stock, worth $3.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,892
Previous 4,960 18.79%
Holding current value
$3.04 Million
Previous $2.07 Million 33.19%
% of portfolio
0.05%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $366,098 - $452,513
932 Added 18.79%
5,892 $2.76 Million
Q1 2024

Apr 29, 2024

BUY
$407.69 - $446.08 $525,104 - $574,551
1,288 Added 35.08%
4,960 $2.07 Million
Q4 2023

Feb 06, 2024

BUY
$343.0 - $410.68 $294,637 - $352,774
859 Added 30.54%
3,672 $1.49 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $42,610 - $45,669
126 Added 4.69%
2,813 $978,000
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $31,127 - $34,839
99 Added 3.83%
2,687 $946,000
Q1 2023

Apr 27, 2023

SELL
$283.23 - $323.1 $27,190 - $31,017
-96 Reduced 3.58%
2,588 $815,000
Q3 2022

Oct 28, 2022

SELL
$273.83 - $305.53 $547 - $611
-2 Reduced 0.07%
2,684 $777,000
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $140,506 - $174,944
-598 Reduced 18.21%
2,686 $757,000
Q4 2021

Feb 07, 2022

BUY
$177.01 - $223.45 $106,206 - $134,070
600 Added 22.35%
3,284 $721,000
Q2 2021

Aug 11, 2021

SELL
$187.49 - $221.1 $150,366 - $177,322
-802 Reduced 23.01%
2,684 $541,000
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $17,803 - $20,752
86 Added 2.53%
3,486 $749,000
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $24,634 - $32,854
119 Added 3.63%
3,400 $804,000
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $218,580 - $259,150
-855 Reduced 20.67%
3,281 $893,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $260,880 - $342,240
1,157 Added 38.84%
4,136 $1.2 Million
Q1 2020

May 07, 2020

BUY
$199.77 - $247.81 $36,557 - $45,349
183 Added 6.55%
2,979 $709,000
Q3 2019

Nov 05, 2019

BUY
$166.23 - $187.09 $429,205 - $483,066
2,582 Added 1206.54%
2,796 $474,000
Q2 2019

Aug 08, 2019

BUY
$164.61 - $190.37 $987 - $1,142
6 Added 2.88%
214 $39,000
Q4 2018

Jan 31, 2019

BUY
$151.91 - $192.21 $6,380 - $8,072
42 Added 25.3%
208 $34,000
Q3 2018

Oct 29, 2018

BUY
$167.73 - $192.74 $9,392 - $10,793
56 Added 50.91%
166 $32,000
Q2 2018

Jul 19, 2018

BUY
$145.72 - $169.96 $1,457 - $1,699
10 Added 10.0%
110 $19,000
Q3 2017

Oct 24, 2017

BUY
$148.13 - $162.24 $14,813 - $16,224
100
100 $15,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.